Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative

Palmer, R., Harrison, M., Cross, E. et al. (1 more author) (2016) Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative. Trials , 17. 71. ISSN 1745-6215

Abstract

Metadata

Authors/Creators:
  • Palmer, R.
  • Harrison, M.
  • Cross, E.
  • Enderby, P.
Copyright, Publisher and Additional Information: © 2016 Palmer et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Excess treatment costs; Clinical trials; Trial set up
Dates:
  • Published: 9 February 2016
  • Accepted: 30 January 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
NATIONAL INSTITUTE FOR HEALTH RESEARCH12/21/01
THE TAVISTOCK TRUST FOR APHASIAUNSPECIFIED
HIGHER EDUCATION FUNDING COUNCIL FOR ENGLANDnone
Depositing User: Symplectic Sheffield
Date Deposited: 14 Apr 2016 10:26
Last Modified: 14 Apr 2016 10:26
Published Version: http://dx.doi.org/10.1186/s13063-016-1208-5
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/s13063-016-1208-5
Related URLs:

Share / Export

Statistics